ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)
China flag China · Delayed Price · Currency is CNY
10.68
+0.11 (1.04%)
At close: Feb 4, 2026

SHE:300254 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
128.98149.52132263.95107.26188.44
Cash & Short-Term Investments
128.98149.52132263.95107.26188.44
Cash Growth
-26.92%13.27%-49.99%146.09%-43.08%24.50%
Accounts Receivable
200.83176.7119.5107.67132.18201.19
Other Receivables
20.4217.6213.588.4410.5834.39
Receivables
221.25194.32133.09116.11142.76235.58
Inventory
135.89132.79120.83103.26108.38122.44
Prepaid Expenses
-2.492.49---
Other Current Assets
31.8321.7518.1424.7217.4932.45
Total Current Assets
517.95500.87406.55508.03375.89578.91
Property, Plant & Equipment
302.29306.56297.52356.42386.14398.68
Long-Term Investments
102.49101.19101.7286.0390.9282.83
Goodwill
311.99311.99316.25320.35339.93359.53
Other Intangible Assets
174.05188.05194.13204.22220.55255.01
Long-Term Deferred Tax Assets
22.2927.6220.1710.9212.1130.09
Long-Term Deferred Charges
34.4624.0519.1619.8815.675.09
Other Long-Term Assets
84.2487.4177.5678.5785.690.38
Total Assets
1,5501,5481,4331,5841,5271,801
Accounts Payable
74.1852.6236.7940.8947.3568.22
Accrued Expenses
12.8744.4650.6854.2757.0158.76
Short-Term Debt
132.92127.9467.4357.6791.03100.53
Current Portion of Long-Term Debt
174.63--33.8493.7398.86
Current Portion of Leases
---1.95.85-
Current Income Taxes Payable
23.949.511.974.653.58-
Current Unearned Revenue
30.7925.6622.9538.2322.9530.36
Other Current Liabilities
116.13310.6242.54368.2378.53133.17
Total Current Liabilities
565.45570.81422.37599.68400.03489.9
Long-Term Debt
194.5153.3139.9174.5233.04106.56
Long-Term Leases
24.2330.3218.8920.995.94-
Long-Term Unearned Revenue
16.5317.4315.3215.3816.1610.67
Long-Term Deferred Tax Liabilities
43.144.4447.4940.5340.9966.67
Other Long-Term Liabilities
128.87133.2410.683.61286.07254.11
Total Liabilities
972.67949.55654.64854.7782.23927.91
Common Stock
256.17248.32241.62241.62227.97227.97
Additional Paid-In Capital
301.89349.58623.91623.91533.47539.72
Retained Earnings
-200.88-223.21-265.4-290.59-172.03-80.6
Treasury Stock
-62.97-31.69----
Total Common Equity
294.21343600.13574.94589.41687.1
Minority Interest
282.88255.18178.3154.77155.17185.51
Shareholders' Equity
577.09598.18778.43729.71744.58872.61
Total Liabilities & Equity
1,5501,5481,4331,5841,5271,801
Total Debt
526.27311.56226.22288.92229.59305.95
Net Cash (Debt)
-397.3-162.05-94.21-24.97-122.33-117.51
Net Cash Per Share
-1.63-0.67-0.39-0.11-0.54-0.55
Filing Date Shares Outstanding
256.17248.32241.62241.62227.97227.97
Total Common Shares Outstanding
256.17248.32241.62241.62227.97227.97
Working Capital
-47.5-69.94-15.82-91.65-24.1489.01
Book Value Per Share
1.151.382.482.382.593.01
Tangible Book Value
-191.83-157.0489.7550.3628.9372.56
Tangible Book Value Per Share
-0.75-0.630.370.210.130.32
Buildings
-210.74217.38230.56231.09232.29
Machinery
-359347.77384.06357.17333.13
Construction In Progress
-15.286.6444.673.9386.27
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.